News and Stocks Pulse

Stocks › FTRE

Fortrea Holdings Inc (FTRE) stock analysis

WEAK BUY 12% confidence · analysed Oct 1, 2026

On Oct 1, 2026, our model rated Fortrea Holdings Inc (FTRE) WEAK BUY with 12% confidence at a price of $19.22. That means the signals lean positive, but they are mixed, so conviction is low.

SectorHealthcare
IndustryBiotechnology
Market cap1770000000.0
Analysed price$19.22

Technical picture

The 14-day RSI is 65, showing healthy upward momentum without being stretched.

MACD is above its signal line, a sign that short-term momentum is turning up.

The price is above both its 50-day and 200-day moving averages, the classic picture of an uptrend.

Volume is only 0.4x its 20-day average; light trading makes the latest move less convincing.

Trend structure and money flow

Market structure shows a bullish break of structure (BOS): price broke a recent swing high in the direction of the trend, which usually signals trend continuation.

The most recent swing high is $18.67 and the swing low is $8.55; traders often treat these as resistance and support.

Price is sitting in a bearish order block, a zone where large sellers stepped in before, so upside may stall here.

Fundamentals

The PEG ratio is 0.34, which looks cheap relative to its expected growth.

The company reports a profit margin of -3.2% and revenue growth of -4.5%.

In its latest quarter it earned $0.23 per share, which beat the $0.18 analysts expected, with revenue -4.5% year over year.

Wall Street's average rating is 2.4 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $20.75.

The next earnings report is expected around Nov 5, 2026; prices often move sharply around earnings.

Trade plan from the model

The model's long / bullish plan uses an entry near $19.35, a target of $20.73 (+7.1%) and a stop-loss at $17.16 (-11.3%).

That is a reward-to-risk ratio of about 0.6 to 1: the potential loss is bigger than the gain, a weak setup.

The plan has a time limit: reassess by Oct 11, 2026 whatever the price does.

Entry$19.35
Target$20.73
Stop-loss$17.16
Reassess byOct 11, 2026

Research notes

FTRE’s bull case is that sell-side sentiment remains constructive, with a consensus Hold and an average target around $22, while Evercore ISI has Outperform at $25 and UBS initiated coverage at Neutral with a $22 target. The bear case is that UBS highlighted margin concerns, and the latest quarter still showed a big gap versus high expectations even though Fortrea beat estimates on the reported numbers and raised full-year guidance. The main recent catalyst is that Fortrea announced Q2 2026 results and subsequent analyst updates, including UBS’s initiation and Evercore’s higher target. The latest public information and price action broadly agree with your last neutral view: the stock has been trading around the high-$19s/near-$20 versus a $22 average target, which is constructive but not decisively bullish.

The model's one-paragraph read

Leans BUY — composite score +0.12 (WEAK BUY). Technicals: RSI 65.2, MACD bullish, price above SMA50. Fundamentals: PEG 0.34, margin -3.2%, revenue growth -4.5%. Financial results: YoY revenue -4.5%, last EPS surprise +27.8%, next earnings 2026-11-05. Smart Money Concepts: BOS bullish (trend continuation), price retesting a bearish order block. FinGPT news read: neutral. Memory: 25 prior look(s); 65% of directional calls matched later price. Internet research: FTRE’s bull case is that sell-side sentiment remains constructive, with a consensus Hold and an average target around $22, while Evercore ISI has Outperform at $25 and UBS initiated coverage at Neutral with a $22 target. The bear case is that UBS highlighted margin concerns, and the latest quarter still showed a big gap versus high expectations even though Fortrea beat estimates on the reported numbers and raised full-year guidance. The main recent catalyst is that Fortrea announced Q2 2026 results and subsequent analyst updates, including UBS’s initiation and Evercore’s higher target. The latest public information and price action broadly agree with your last neutral view: the stock has been trading around the high-$19s/near-$20 versus a $22 average target, which is constructive but not decisively bullish. Suggested levels: entry $19.35, target $20.73, stop-loss $17.16, exit by 2026-10-11 (10-calendar-day max hold (time-stop; reassess by this date regardless of P&L)).

Past ratings for FTRE

Of the last 3 directional calls on FTRE, 3 pointed the right way by the most recent analysis (100%). Past calls do not guarantee future results.

DateVerdictConfidencePriceMove since
Oct 1, 2026WEAK BUY12%$19.22—
Sep 15, 2026SKIP7%$18.62+3.2%
Sep 4, 2026SKIP3%$18.65+3.1%
Sep 2, 2026SKIP3%$18.70+2.8%
Aug 31, 2026WEAK BUY22%$18.36+4.7%✔ right direction
Aug 27, 2026WEAK BUY13%$18.70+2.8%✔ right direction
Aug 26, 2026SKIP3%$18.20+5.6%
Aug 25, 2026SKIP10%$18.37+4.6%
Aug 24, 2026SKIP10%$18.10+6.2%
Aug 21, 2026WEAK BUY28%$18.39+4.5%✔ right direction

"Move since" compares each call's price with the latest analysed price.

Other Healthcare stocks we cover

HALO · HUM · IART · ICLR · IRWD · JNJ · KMDA · LH · LLY · MDT · NRC · NVO

Frequently asked questions

Is FTRE a buy right now?

As of Oct 1, 2026, our automated model rates Fortrea Holdings Inc (FTRE) WEAK BUY with 12% confidence: the signals lean positive, but they are mixed, so conviction is low. This is a model output for education, not personal investment advice.

What is the price target for FTRE?

The model's most recent plan targets $20.73 with a stop-loss at $17.16, from an entry near $19.35.

When does Fortrea Holdings Inc report earnings next?

The next earnings report is expected around Nov 5, 2026.

What does a WEAK BUY rating mean?

A WEAK BUY rating means the signals lean positive, but they are mixed, so conviction is low.

For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.